Hemex
Europe, Basel-Landschaft, Switzerland, Liestal
Description
Hemex AG helps its clients to develop pharmaceuticals and medical devices.
Investor Profile
Hemex has made 13 investments, with 0 in the past 12 months and 38% as lead.
Stage Focus
- Seed (38%)
- Series A (23%)
- Series B (15%)
- Convertible Note (8%)
- Pre Seed (8%)
- Series Unknown (8%)
Country Focus
- Switzerland (92%)
- Sweden (8%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Life Science
- Medical
- Therapeutics
- Hardware
- Information Technology
- Artificial Intelligence (Ai)
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
